The Effects of Telerehabilitation in Patients With COPD (COPD)
5 de mayo de 2021 actualizado por: Beyza Karakaş, Kırıkkale University
The Effects of Telerehabilitation on Respiratory Functions, Quality of Life, Exercise Capacity, Fatigue and Psychosocial Factors in Patients With COPD
Chronic Obstructive Pulmonary Disease is a serious public health problem worldwide and it is a leading cause of mortality and morbidity. Nowadays, COPD patients are increasing in all societies and the problems that arise during the life of these patients increase the need for care and rehabilitation. Pulmonary rehabilitation has proven to be the best supportive treatment for individuals with COPD. However, there are difficulties in rehabilitation practices in terms of the fragility of patients, transportation and access problems. Telerehabilitation allows patients who cannot access rehabilitation due to their geographical, economic or physical disabilities to benefit from rehabilitation services. There are different studies demonstrating the effect of telerehabilitation in COPD patients and confirming that it is safe, but it is a developing area and has a limited area of use.
In this randomized controlled study, it is aimed to examine the effect of telerehabilitation training on respiratory functions, exercise capacity, quality of life, fatigue and psychosocial factors in individuals with COPD via video conferencing including respiratory exercises and postural exercises.
Descripción general del estudio
Tipo de estudio
Intervencionista
Inscripción (Anticipado)
30
Fase
- No aplica
Contactos y Ubicaciones
Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.
Estudio Contacto
- Nombre: Beyza Karakaş
- Número de teléfono: 05062187342
- Correo electrónico: beyzakarakas071@gmail.com
Ubicaciones de estudio
-
-
-
Kırıkkale, Pavo
- Reclutamiento
- Kırıkkale High Specialization Hospital
-
Contacto:
- Selma Demir
- Número de teléfono: 05054895758
- Correo electrónico: drmed64@gmail.com
-
-
Criterios de participación
Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.
Criterio de elegibilidad
Edades elegibles para estudiar
40 años a 80 años (Adulto, Adulto Mayor)
Acepta Voluntarios Saludables
No
Géneros elegibles para el estudio
Todos
Descripción
Inclusion Criteria:
- Having been diagnosed with chronic obstructive pulmonary disease according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) criteria
- Not having an attack in the last 2 months
- Volunteering to participate in the study
- Being between the ages of 40-80
- To have a device that can be used in telerehabilitation application and an active internet connection.
Exclusion Criteria:
- Unstable angina, previous myocardial infarction, severe congestive heart failure resistant to medical therapy, uncontrolled hypertension, cancer, neurological or musculoskeletal disorders with functional limitations
- Currently addicted to alcohol or drugs
- Having an injury to the lower extremity such as sprains, sprains or fractures in the last 6 months, not being able to perform independent ambulation
- Having serious vision and hearing problems
- Having severe cognitive impairment
Plan de estudios
Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Cuidados de apoyo
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Ninguno (etiqueta abierta)
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Sin intervención: Grupo de control
|
|
|
Experimental: Grupo de tratamiento
|
Telerehabilitation including pulmonary rehabilitation and posture exercises at 8 weeks in total with 2 sessions per week
Otros nombres:
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Change from Baseline in respiratory functions on the spirometry at week 8
Periodo de tiempo: Baseline - Week 8
|
Spirometry is a standard test doctors use to measure how well your lungs are functioning.
The test works by measuring airflow into and out of your lungs.Spirometry measures two key factors: expiratory forced vital capacity (FVC) and forced expiratory volume in one second (FEV1).
|
Baseline - Week 8
|
|
Change from Baseline in exercise capacity on six-minute walk test at week 8
Periodo de tiempo: Baseline - Week 8
|
The six-minute walk test measures the distance an individual is able to walk over a total of six minutes on a hard, flat surface.
The goal is for the individual to walk as far as possible in six minutes.A lower score (reflecting less distance covered in 6 minutes) indicates worse function.
|
Baseline - Week 8
|
|
Change from Baseline in health-related quality of life on Saint George's Respiratory Questionnaire at week 8
Periodo de tiempo: Baseline - Week 8
|
Disease-specific instrument designed to measure impact on overall health, daily life, and perceived well-being in patients with obstructive airways disease.Scores range from 0 to 100, with higher scores indicating more limitations.
|
Baseline - Week 8
|
|
Change from Baseline in psychosocial factors on Beck Depression and Beck Anxiety Inventory at week 8
Periodo de tiempo: Baseline - Week 8
|
Beck Depression Inventory is a self-assessment scale that determines the risk of individuals in terms of depression and measures the level of depressive symptoms and the change in severity.Beck Anxiety Inventory is a likert type self-assessment scale that determines the frequency of anxiety symptoms experienced by individuals.
The high score the individual gets from the scale indicates the severity of anxiety experienced.
|
Baseline - Week 8
|
|
Change from Baseline in fatigue on COPD and Asthma Fatigue Scale at week 8
Periodo de tiempo: Baseline - Week 8
|
The COPD and Asthma Fatigue Scale , was developed for use in clinical trials and other studies in respiratory diseases.
The COPD and Asthma Fatigue Scale was intended to be sufficiently comprehensive to capture fatigue experienced by patients with either asthma or COPD, yet be brief and patient centered.
|
Baseline - Week 8
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Change from Baseline in dyspnea on Modified Medical Research Council Dyspnea Scale at week 8
Periodo de tiempo: Baseline - Week 8
|
The modified Medical Research Council (mMRC) scale is the most commonly used validated scale to assess dyspnea in daily living in chronic respiratory diseases.
It is a scale scored between 0 and 5 based on various factors causing dyspnea.
|
Baseline - Week 8
|
Colaboradores e Investigadores
Aquí es donde encontrará personas y organizaciones involucradas en este estudio.
Patrocinador
Investigadores
- Silla de estudio: Meral Sertel, Associate professor at Kırıkkale University
- Director de estudio: Beyza Karakaş, Graduate student at Kırıkkale University
- Investigador principal: Selma Demir, Chest Diseases Specialist at Kırıkkale High Specialization Hospital
Fechas de registro del estudio
Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.
Fechas importantes del estudio
Inicio del estudio (Actual)
1 de abril de 2021
Finalización primaria (Anticipado)
1 de septiembre de 2021
Finalización del estudio (Anticipado)
1 de diciembre de 2021
Fechas de registro del estudio
Enviado por primera vez
5 de mayo de 2021
Primero enviado que cumplió con los criterios de control de calidad
5 de mayo de 2021
Publicado por primera vez (Actual)
10 de mayo de 2021
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
10 de mayo de 2021
Última actualización enviada que cumplió con los criterios de control de calidad
5 de mayo de 2021
Última verificación
1 de mayo de 2021
Más información
Términos relacionados con este estudio
Palabras clave
Otros números de identificación del estudio
- KKUniversity
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
No
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
No
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .